| P50 | author | Steven Rosenberg | Q2347448 |
| | Alena Gros | Q38801343 |
| P2093 | author name string | Anna Pasetto | |
| | Paul Robbins | |
| | Jessica S Crystal | |
| | Maria Parkhurst | |
| | Todd Prickett | |
| P2860 | cites work | cDNA sequences of two inducible T-cell genes | Q24621040 |
| | Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen | Q24623215 |
| | Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1 | Q24633445 |
| | Tumor-specific Th17-polarized cells eradicate large established melanoma | Q24648032 |
| | Cancer regression in patients after transfer of genetically engineered lymphocytes | Q24654976 |
| | Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method | Q24815448 |
| | Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine | Q27853005 |
| | Dominant TCR-alpha requirements for a self antigen recognition in humans | Q28215549 |
| | TNF/TNFR family members in costimulation of T cell responses | Q28240053 |
| | Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma | Q28292742 |
| | Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA | Q29620083 |
| | Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 | Q29620608 |
| | Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias | Q29622949 |
| | CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor. | Q30573747 |
| | Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells | Q30621114 |
| | Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries | Q33316579 |
| | Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer | Q33667666 |
| | Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases | Q33788932 |
| | Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions. | Q33851742 |
| | Paths to stemness: building the ultimate antitumour T cell. | Q34300932 |
| | Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells | Q34310912 |
| | Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. | Q34557953 |
| | T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. | Q34621730 |
| | MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy | Q34700253 |
| | A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response | Q35182795 |
| | Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice | Q35223241 |
| | Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities | Q35850673 |
| | Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment | Q35860034 |
| | Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans | Q36060239 |
| | Immune epitope database analysis resource | Q36088427 |
| | Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes | Q36165605 |
| | Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. | Q36286122 |
| | Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability | Q36286127 |
| | Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes | Q36327157 |
| | High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens | Q36471584 |
| | Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy | Q36637039 |
| | NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11 | Q36749382 |
| | Mutant MHC class II epitopes drive therapeutic immune responses to cancer | Q36817092 |
| | Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities | Q37193866 |
| | Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. | Q37389018 |
| | Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy. | Q37590119 |
| | PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors | Q37726682 |
| | Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition | Q38199350 |
| | The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens. | Q38423398 |
| | Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients | Q38792012 |
| | Immunogenicity of somatic mutations in human gastrointestinal cancers. | Q38823554 |
| | Profiling the T-cell receptor repertoire of patient with pleural tuberculosis by high-throughput sequencing | Q39137438 |
| | Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity. | Q39356556 |
| | A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer. | Q39621147 |
| | Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor | Q39647119 |
| | Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer | Q41101308 |
| | A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days | Q42244370 |
| | 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1. | Q44187638 |
| | In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses | Q44493927 |
| | Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. | Q45729348 |
| | Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo | Q48020828 |
| | Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach | Q48559352 |
| | Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation. | Q51017397 |
| | 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses. | Q51996548 |
| | Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. | Q52961647 |
| | Design and use of conditional MHC class I ligands. | Q53637625 |
| | Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer | Q57152489 |
| | 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function | Q78057869 |
| | Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses | Q78759402 |
| | CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy | Q81737517 |
| | High-throughput pairing of T cell receptor α and β sequences | Q85935018 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2491-2505 | |
| P577 | publication date | 2016-11-08 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression | |
| P478 | volume | 23 | |